Fundraising Fox
YuanBio Venture Capital
Venture capitalSuzhou · Seed–Growth · 18 people tracked
Find your way into YuanBio Venture Capital
Sign up to see every warm intro you have to YuanBio Venture Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the YuanBio Venture Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
YuanBio invests in highly innovative healthcare companies across China at early and growth stages while maintaining a global perspective on industry developments. Its focus spans biotech, medical devices, IVD and healthcare services. The firm leverages its base in Suzhou bioBay and close ties with the bioBay platform for high-quality deal flow, information exchange and post-investment support. Its team combines scientific expertise, industry experience and early-stage investment knowledge, supported by senior experts and consultants. YuanBio adds value through business development, management and operations, fundraising, and recruitment assistance, aiming to become one of China's most successful healthcare venture capital firms.
Source: firm website, verified Aug 3, 2026.
Team · 18 people
from the firm's website & public directories
What they invest in
from 14 of 74 portfolio companiesHealthtech ×13Biotech ×11Medical Devices ×11Digital Health ×6Hardware ×2Advanced Manufacturing ×1Deep Tech ×1Enterprise Software ×1
HQs:China×11United States×2
Investments · 74 tracked
founders shown can be your intro pathBy year:2026 · 12024 · 12021 · 13 dated
Zai Lab is a global biopharmaceutical company developing and commercializing therapies in oncology, immunology, neuroscience, and infectious disease, with operations in China and the United States.
BiotechHealthtechMedical Devices
Samantha (Ying) Du(Founder, Chief Executive Officer, Chairperson of the Board of Directors)inYajing Chen(Chief Financial Officer)inRafael G. Amado(President, Head of Global Research and Development)inF. Ty Edmondson(Chief Legal Officer)inJosh Smiley(President and Chief Operating Officer)Samantha Du(Founder)
Co-investorsQiming Venture PartnersVivo CapitalAdvantech CapitalHongShan Capital GroupKleiner PerkinsSequoia Capital
MacroLux Medical Technology develops endoscopic imaging systems and related medical devices.
HardwareHealthtechMedical DevicesShenzhen, CN
Co-investorsDalton VentureLegend CapitalB Capital GroupB4 Capital
.jpeg){kind=logo}
An innovative biopharmaceutical company focused on developing therapies for chronic kidney disease across multiple clinical stages, with a pipeline of eight products covering conditions such as hyperphosphatemia, renal anemia, IgA nephropathy, and diabetic kidney disease.
BiotechDigital HealthHealthtechMedical DevicesShanghai, CN
Co-investorsLAVLilly Asia VenturesQuan Capital3E Bioventures Capital3H Health InvestmentSherpa Healthcare Partners
A pharmaceutical and life sciences company developing drug pipelines and conducting research and innovation activities.
BiotechHealthtechMedical DevicesShanghai, CN
Du JinhaoGuo Jianhui(Co-founder)
Co-investorsLAVLilly Asia Ventures
Ark Biosciences is a biopharmaceutical company developing small molecule drugs for infectious diseases, respiratory conditions, neuropsychiatric disorders, and rare diseases.
BiotechDigital HealthHealthtechMedical DevicesShanghai, CN
Co-investorsDecheng CapitalQiming Venture Partners
Provider of R&D and one-stop production services to leading pharmaceutical companies worldwide.
Co-investorsHongShan Capital Group
大米和小米 (DMHXM) operates a network of over 80 directly-run centers across more than 30 Chinese cities providing in-person early intervention and rehabilitation therapy for children with autism and developmental disorders, staffed by BCBA/BCaBA-certified therapists and experienced supervisors.
Digital HealthHealthtechWellness & FitnessShenzhen, CN
Co-investorsOrbiMed
A biopharmaceutical company developing CAR-T cell therapies for cancer treatment.
BiotechHealthtechMedical DevicesShanghai, CN
Co-investorsAcorn Pacific VenturesARCH Venture PartnersShiyu CapitalTemasek
PegBio is a biotech company founded in 2008 that develops innovative therapies for chronic diseases, with a focus on endocrine and metabolic disorders.
BiotechHealthtechHangzhou, CN
Quantum-Si develops next-generation protein sequencing technology that enables single amino acid detection by combining biology, chemistry, artificial intelligence, and semiconductor technology.
BiotechDeep TechHardwareMedical Devices
Jeff Hawkins(CEO)inJeff Keyes(Chief Financial Officer)inChristian LaPointe(General Counsel)inTodd Rearick(Chief Technology Officer)inLindsay Thompson(Chief Human Resources Officer)in
Co-investorsForesite CapitalHighCape Capital
Shuwen Biotech develops molecular and immunodiagnostic products for women's health, including breast cancer subtyping kits, nucleic acid extraction systems, and point-of-care tests for pregnancy complications.
BiotechDigital HealthFemTechHealthtechMedical DevicesShanghai, CN
Sironax is a biopharmaceutical company focused on the discovery and development of therapies for neurodegenerative, inflammatory and immunological, metabolic, and rare diseases.
BiotechHealthtechLongevityWaltham, US
Dr. Xiaodong Wang(Founder)Dr. Zhiyuan Zhang(Founder)
Co-investorsARCH Venture PartnersF-Prime CapitalCBC GroupEight Roads VenturesFuture InnovationGaorong Capital+6 more
TriApex provides contract research organization (CRO) services supporting pharmaceutical and biologics development, including preclinical studies, clinical trial design, regulatory strategy, and post-market safety monitoring.
BiotechDigital HealthEnterprise SoftwareHealthtechMedical DevicesNanjing, CN
Co-investorsApricot Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AIVFOAlltechAscentage PharmaATKCBasecare MedicalBeiGeneBeikang MedicalBestview LaserBGI Genomics (华大基因)BrightGeneCapitalbio TechnologyCF PharmTechCreative SciencesDeepCytoDymindEnzymasterFuture VisionGBSGenskeyH-BioHC SemiTekHengruiHengsheng MedicalHenlius BiotechiKangInnoModels BioInnoventiXINGJingfeng PharmaKangfu ZhijiaKangning HospitalKawin TechnologyKintor PharmaLegend CapitalLiferealLongwood ValleyNano-MicroNervtexNovaxelgenPanomixPharmacodiaPortenRainsureRongchang BioShengNuo BiotechSinobioway MedicineSINQISnibe DiagnosticSorrentoSunvouTigermedTongshu GeneUnionStrongUnited ImagingXABTXpeedic TechnologyYHLO BiotechZylox-Tonbridge
Exits · 3
3 IPOs · showing 2Adlai NortyeNASDAQ: ANLZai LabNASDAQ: ZLAB
Portfolio news
latest coverage across their companiesSironax · sironax.com · Nov 19, 2025
MacroLux · microlite.cn · Oct 23, 2025
Frequently asked questions
- How many investments has YuanBio Venture Capital made?
- YuanBio Venture Capital has 74 tracked investments, 3 of which have exited, including 2 dated in the last 24 months.
- What stage does YuanBio Venture Capital invest at?
- YuanBio Venture Capital invests at the Seed, Series A, Series B, Growth stages.
- What sectors does YuanBio Venture Capital focus on?
- YuanBio Venture Capital focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
- Where is YuanBio Venture Capital located?
- YuanBio Venture Capital is headquartered in Suzhou, CN.
- Does YuanBio Venture Capital lead rounds?
- YuanBio Venture Capital typically participates in rounds rather than leading them.
- Who does YuanBio Venture Capital co-invest with?
- YuanBio Venture Capital most often shares deals with ARCH Venture Partners, Qiming Venture Partners, F-Prime Capital, among 12 tracked co-investors.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.